Clinical Trials Directory

Trials / Unknown

UnknownNCT02403349

Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
105 (actual)
Sponsor
Ajou University School of Medicine · Academic / Other
Sex
All
Age
30 Years
Healthy volunteers
Not accepted

Summary

Confirm central blood pressure reduction effect of Fimasartan, Valsartan and Atenolol and compare correlation with the measured peripheral (central blood pressure, pulse wave velocity, and flow-mediated dilation) and cerebral blood flow factors (transcranial doppler findings, cerebral blood flow volume) in acute ischemic stroke patients with hypertension.

Conditions

Interventions

TypeNameDescription
DRUGFimasartan
DRUGValsartan
DRUGAtenolol

Timeline

Start date
2012-05-01
Primary completion
2015-05-01
Completion
2015-09-01
First posted
2015-03-31
Last updated
2015-03-31

Source: ClinicalTrials.gov record NCT02403349. Inclusion in this directory is not an endorsement.

Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol (NCT02403349) · Clinical Trials Directory